Promoters stake sales surge almost 7-fold in Q1 as they cash in on high market valuations
Shares sold by promoters on the country's top two exchanges increased 6.69 times on a quarterly basis and 1.54 times from a year earlier to ₹2.61 trillion, according to PRIME Database, which cited insider trading disclosures in the first quarter of FY26.
The highest-selling promoter was the government, which sold shares worth ₹29,963 crore in ITI Ltd. Among the others, Pastel, a subsidiary of Singapore-based Singtel, sold shares worth ₹12,880 crore in Bharti Airtel, and the Chinkerpoo Family Trust set up by Rakesh Gangwal, co-founder of IndiGo, sold shares worth ₹10,408 crore in InterGlobe Aviation.
Promoter stake sales in Vishal Mega Mart and Wipro were among the top five.
In the first six months of 2025, promoters have already sold 65% of the stake worth ₹4.61 trillion that they offloaded in 2024.
Promoters are seizing the current favourable market conditions to dilute their stakes in companies as valuations are currently significantly higher than their intrinsic worth, said Siddarth Bhamre, head of institutional research at Asit C Mehta Investment Intermediaries Ltd.
Many promoters believe that their businesses are valued far above their actual worth and this valuation gap has prompted them to capitalise on the opportunity, resulting in a surge in stake sales, Bhamre added.
The Nifty 50's current PE is 22.8x compared with 19.8x on 28 March, while its 12-month forward PE is 19.9x. The index has jumped 8.49% from April 1 to June 30.
The PE of InterGlobe Aviation when the stake was sold on 25 May was 28.29x compared with an average of 18.35x in Q1 a year earlier.
The PE of Vishal Mega Mart when Samayat Services LLP sold ₹10,221 crore of shares on 18 June was 90.42x compared with an average of 22.81x in the January-March quarter of 2024.
Investment avenues
Apart from rising valuations, promoters may sell shares to meet minimum public shareholding norms, repay debt or raise funds to invest elsewhere.
'Individual promoters are selling stakes either to deleverage the balance sheet at a personal level or to book profit and diversify into other investment avenues, while continuing to hold a majority stake in the company," said Sunny Agrawal, head of fundamental equity research at SBI Securities.
The same promoters may later invest in the business and again increase their stakes through warrants, rights issues, or preferential allotments, he added.
Of the ₹2.61 trillion worth of shares sold by promoters, offers-for-sale (OFS) made up ₹8,284 crore, while shares sold in block or bulk deals added up to ₹60,900 crore, as per PRIME Database. OFS, block and bulk deals are a part of the insider trading filings but do not make up all stake sales by promoters.
Promoters selling stakes via bulk or block deals increased 64% YoY and 17 times sequentially in Q1. Promoters who sold shares via OFS increased 25 times YoY and 69% sequentially.
The markets seem to remain elevated on the back of falling interest rates, which may keep promoter stake sale activity higher in the coming quarters, said Vinit Bolinjker, head of research at Ventura Securities.
Agrawal of SBI Securities added that if market sentiment remains buoyant, promoter stake sales will continue.
'The market sentiment looks positive as global uncertainties have receded of late. And a rate cut and tax cut may boost consumption. Plus, private capex is picking up and earnings growth is likely to go back to two-digit numbers in Q2 of FY26," Agrawal added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
21 minutes ago
- Business Standard
Bank of Baroda stock fluctuates after mixed Q1 show; hold or exit?
Shares of Bank of Baroda recouped losses after it fell over 2 per cent on Monday morning deals as analysts termed the lender's first quarter performance as a mixed bag, with a modest growth in net profit. The public-sector lender's stock fell as much as 2.33 per cent during the day to ₹237.7 per share, the biggest intraday rise since June 19 this year. However, the stock pared losses to trade 0.3 per cent higher at ₹244.3 apiece, compared to a 0.02 per cent decline in Nifty 50 as of 11:00 AM. Shares of the company have been in a range-bound pattern since June. The counter has risen 1.5 per cent this year, compared to a 5 per cent advance in the benchmark Nifty 50. Bank of Baroda has a total market capitalisation of ₹1.26 trillion. Bank of Baroda Q1 results The lender's net profit grew 1.9 per cent year-on-year (Y-o-Y) to ₹4,541 crore in the first quarter of 2025-26 (Q1FY26), aided by treasury income, amid pressure on net interest margin. Net interest income (NII) -- the difference between interest earned and interest expended -- fell 1.4 per cent Y-o-Y to ₹11,435 crore. Net interest margin (NIM) from domestic operations fell to 2.91 per cent in Q1FY26, down from the 3.18 per cent in Q1FY25. BoB reported 12.6 per cent Y-o-Y credit growth in overall advances to ₹12.07 trillion. The domestic book grew by 12.4 per cent. While retail advances increased 17.5 per cent, corporate loans saw 4.2 per cent Y-o-Y growth in Q1FY26. Home loans grew by 16.5 per cent. Bank of Baroda asset quality The asset quality profile improved with gross non-performing assets (NPAs) declining to 2.28 per cent from 2.88 per cent a year ago. The net NPAs fell to 0.60 per cent from 0.69 a year ago. The provision coverage ratio, including those for write-offs, stood at 93.18 per cent in June 2025. Lender's capital adequacy ratio stood at 17.19 per cent with the common equity tier I (CET-1) of 17.61 per cent. Analysts on Bank of Baroda Q1 The lender reported a mixed performance in Q1FY26, marked by slower loan growth, higher slippages, and a relatively resilient NIM, Nuvama Institutional Equities said. While BoB's international loan quality remains more volatile than peers, overseas loan growth continues to outpace domestic, Nuvama said. NIM resilience was aided by slower marginal cost of funds-based lending rate (MCLR) cuts and repricing of bulk deposits, despite having a similar external benchmark lending rate (EBLR) mix of 48 per cent as peers. However, Nuvama anticipates a sharper NIM decline for BoB in the coming quarters. Nuvama raised its target price to ₹280 (from ₹260), and maintained its rating at 'Buy'. The near-term pressure on NIMs is expected to continue before a potential recovery in the second half of the financial year, Axis Securities said. A sharper-than-expected contraction in NIMs could pose risks to the bank's ability to deliver a 1 per cent return on assets (RoA), it said The bank is actively working to strengthen its fee income profile, while operating expense growth is expected to remain controlled and slightly below business growth, Axis said. "With no major asset quality concerns on the horizon, credit costs are likely to stay contained, it added. ALSO READ: Analysts at Antique Stock Broking said that the bank delivered a mixed performance, with RoA supported by higher non-core income and a relatively smaller contraction in NIM compared to peers. However, elevated credit costs and higher slippages were notable concerns, it said. Bank of Baroda has consistently maintained RoA above 1 per cent for the past 12 quarters, and this trend is expected to continue, Antique said. The stock appears reasonably priced, with the brokerage maintaining its 'Buy' rating.
Time of India
21 minutes ago
- Time of India
LVMH said to be in talks to offload fashion label Marc Jacobs
French luxury goods group LVMH is in discussions with multiple buyers to offload its fashion label Marc Jacobs , people familiar with the matter told Reuters on Friday. The Bernard Arnault-led company has been holding talks with potential buyers including Reebok-owner Authentic Brands Group and WHP Global , the sources said, who asked not to be named because the discussions are confidential. Authentic Brands declined to comment on the matter while WHP did not immediately respond. Brookstone's owner Bluestar Alliance is also a suitor for Marc Jacobs, which could be worth around $1 billion, according to the Wall Street Journal, which earlier reported the news. LVMH, Marc Jacobs and Bluestar Alliance did not immediately respond to requests for comments on the WSJ report. In 2024, Bloomberg reported that LVMH was exploring strategic options for the label with advisers after receiving interest from potential buyers, though the company denied the claim at the time. Founded in 1984 by American designer Marc Jacobs, the luxury fashion brand is renowned for its eclectic, bold designs that blend high fashion with street style. In 1997, LVMH tapped Jacobs to lead the Louis Vuitton brand and acquired a stake in the designer's eponymous label. The Journal said that a deal could be finalized soon, provided talks do not fall apart. LVMH has recently been offloading some of its brands to streamline its portfolio. Last year, it sold the Off-White clothing brand, founded in 2012 by the late Virgil Abloh, to New York-based company Bluestar Alliance for an undisclosed value. Another label, Stella McCartney, earlier this year, repurchased the minority stake held by LVMH in the house she founded about five years after the luxury group bought it. McCartney, who famously does not use leather or fur, said it will continue to advise LVMH chief Arnault and the group's executive team on sustainability matters. Dealmaking in the luxury retail sector has drawn attention in Europe. Earlier this year, Prada acquired Versace from Capri Holdings, combining two iconic Italian fashion brands in a $1.4 billion deal. LVMH's second-quarter sales, which include products such as Louis Vuitton handbags, Dior dresses and Moet & Chandon champagne, came in slightly below market expectations. The company's shares rose with analysts pointing to hopes on the horizon as the group said it saw some signs of recovery in the key Chinese market. Deutsche Bank analyst Adam Cochrane said that while the second-quarter results were not "stellar," there were some "glimmers of hope." French luxury brands have been navigating prolonged market challenges, including a downturn and the potential impact of U.S. import tariffs.
Mint
22 minutes ago
- Mint
Shares to buy for the short term: Jigar Patel of Anand Rathi recommends THESE 2 stocks
Shares to buy for the short term: The Indian stock market has been in corrective mode for the last few weeks due to the delayed India-US trade deal, the foreign capital outlook, and uninspiring Q1 earnings. The Sensex and the Nifty 50 have been on losing streak for the last four consecutive weeks, on a weekly basis. So far this month, both indices are down nearly 3 per cent each. Last Friday, the Nifty 50 fell almost 1 per cent to end at 24,837, falling below its critical support of 25,000. Jigar S. Patel, Senior Manager of Equity Research at Anand Rathi Share and Stock Brokers, underscored that the Nifty's reversal from 25,250 has brought it precariously close to a breakdown below the previous swing low at 24,850, a development considered negative for market sentiment. Patel pointed out that the index is now hovering around a crucial rising channel support, and a close below 24,800 could confirm this breakdown, placing the next support at 24,450 in the spotlight. A breach of the 24,450 may usher in a more pronounced corrective phase. On the upside, recapturing the 25,000 level will be essential for the bulls to regain momentum, said Patel. The expert further added that from a positioning perspective, the current long-short ratio in index futures has dropped below 15 per cent, signalling a predominance of short bets. "While this high concentration of shorts increases nervousness, it also raises the odds for a sharp short-covering rally if a positive trigger emerges. Until clearer signals appear, a cautious outlook on the broader time frame is recommended," said Patel. Jigar Patel recommends buying shares of TCS and Sun Pharma for the next two to three weeks. TCS has been on a downward trajectory since mid-May 2025, consistently forming lower highs and lower lows. This bearish structure has resulted in a correction of nearly ₹ 440 — a decline of approximately 12.32 per cent. However, the stock now stands at a technically significant zone, where both time and price confluence suggest a potential trend reversal. Historically, key pivot highs and lows in TCS have often occurred within a 25–38 day cycle. Interestingly, this window aligns with both the Lucas number (29) and Fibonacci number (34), adding credence to the time-based support. Adding to the technical outlook, a bullish Bat Harmonic Pattern is taking shape around the ₹ 3,080-3,100 mark, coinciding with the S1 quarterly floor pivot, reinforcing the likelihood of a strong base. Moreover, the MACD histogram is showing signs of exhaustion in negative momentum, with shrinking red bars indicating a possible shift in trend. "In light of these technical factors, traders may consider initiating long positions in the ₹ 3,140–3,100 zone in a staggered manner, targeting an upside move toward ₹ 3,430, with a protective stop loss at ₹ 2,965 on a daily closing basis,' said Patel. TCS technical chart Sun Pharma has formed a robust base in the ₹ 1,650–1,680 range, coinciding with the S3 Camarilla monthly pivot, signalling a key support zone. This area also aligns with a rising trendline and the lower median line of a pitchfork, creating a compelling technical confluence that could attract renewed buying interest. "The multiple support factors at play increase the probability of a bullish reversal from current levels. A decisive move above this consolidation zone could open the door for a fresh leg higher,' said Patel. Patel suggests an entry zone of ₹ 1,705–1,695 for the stock, with a target price of ₹ 1,800, and a stop loss of ₹ 1,650 on a daily closing basis. Sun Pharma technical chart Read all market-related news here
